Format

Send to

Choose Destination
J Hosp Infect. 2019 Oct;103(2):156-159. doi: 10.1016/j.jhin.2019.04.012. Epub 2019 Apr 27.

Screening for carbapenemase-producing Enterobacteriaceae in previous carriers readmitted to hospital: evaluation of a change in screening policy.

Author information

1
Public Health England North West, Manchester, UK. Electronic address: angela.tucker@phe.gov.uk.
2
Manchester University NHS Foundation Trust, Manchester, UK.
3
Public Health England North West, Manchester, UK.
4
Field Service North West, Liverpool, UK.

Abstract

Carbapenemase-producing Enterobacteriaceae (CPE) are a growing problem in UK hospitals. Preventing transmission requires early detection. This study evaluates a new screening policy for patients with a history of blaKPC-associated CPE (KPC-CPE) in a higher incidence hospital. Previous policy assumed 'once positive always positive'. New policy uses rapid screening and risk assessment. Results show that most (76.5%) patients with a history of KPC-CPE do not have detectable KPC-CPE on readmission or during their subsequent hospital stay but that repeat screening after an initial negative result is required. The new policy takes a risk-based approach while prioritizing isolation facilities in a higher incidence trust.

KEYWORDS:

Carbapenem-resistant Enterobacteriaceae; Carbapenemase-producing; Evaluation; Hospitals; Screening

PMID:
31039383
DOI:
10.1016/j.jhin.2019.04.012

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center